Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    12778130 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix Cancer
Condition: Cervical Cancer
Interventions: Drug: Bevacizumab;   Drug: Carboplatin;   Radiation: Radiation Therapy

Study has passed its completion date and status has not been verified in more than two years.